Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 3/20 | 0.64 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.55 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.55 |
| ▸ | F10 | P00742 | 2/20 | 0.50 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.50 |
| ▸ | CCR5 | P51681 | 1/20 | 0.50 |
| ▸ | KDM1A | O60341 | 3/20 | 0.49 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1752470 | 1.00 | RORC (0.64) | RORCS1PR5S1PR1F10FUCA1 | |
| SCHEMBL14371541 | 1.00 | RORC (0.64) | RORCS1PR5S1PR1F10FUCA1 | |
| SCHEMBL1752417 | 1.00 | RORC (0.64) | RORCS1PR5S1PR1F10FUCA1 | |
| SCHEMBL12303485 | 1.00 | RORC (0.64) | RORCS1PR5S1PR1F10FUCA1 | |
| SCHEMBL419234 | 1.00 | RORC (0.64) | RORCS1PR5S1PR1F10FUCA1 | |
| SCHEMBL1751711 | 1.00 | RORC (0.64) | RORCS1PR5S1PR1F10FUCA1 | |
| SCHEMBL2226168 | 0.91 | RORC (0.62) | RORCS1PR5S1PR1 | |
| SCHEMBL1976054 | 0.91 | RORC (0.62) | RORCS1PR5S1PR1 | |
| SCHEMBL2778415 | 0.91 | RORC (0.62) | RORCS1PR5S1PR1 | |
| SCHEMBL8210627 | 0.91 | RORC (0.62) | RORCS1PR5S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1506779-B1 | (3-(4-(Pyridin-2-ylamino)-butyryl)-2,3,4,4a,9,9a-hexahydro-1H-3-aza-fluoren-9-yl)-acetic acid derivatives and related tricyclic indanyls as alphaVbeta3 and alphaVbeta5 integrin inhibitors for the treatment of cancer and unstable angina | JANSSEN PHARMACEUTICA NV (BE) | 2006-07-12 | — | — | EP | disclosed |
| EP-1506779-A1 | (3-(4-(Pyridin-2-ylamino)-butyryl)-2,3,4,4a,9,9a-hexahydro-1H-3-aza-fluoren-9-yl)-acetic acid derivatives and related tricyclic indanyls as alphaVbeta3 and alphaVbeta5 integrin inhibitors for the treatment of cancer and unstable angina | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-02-16 | — | — | EP | disclosed |